Latest Trials Latest NewsFAQ

Indiana University Foundation, Inc.

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1820-01-20

Employees: 10K

Market Cap: -

Website: http://www.indiana.edu

Clinical Trials

Zinc Status and Growth in Cystic Fibrosis

Completed

Conditions: Cystic
Fibrosis

Interventions: Biological: Serum Zn
Biological: Red Blood Cell Zn

First Posted Date: 2020-03-10

Last Posted Date: 2023-03-20

Lead Sponsor: Indiana University

Target Recruit Count: 35

Registration Number: NCT04302428

Locations: 🇺🇸
Riley Hospital for Children at Indiana University Health, Indianapolis, Indiana, United States

Thoracic Epidural Analgesia Versus Rectus Sheath Block Versus Surgeon Infiltration With Liposomal Bupivacaine or Standard Bupivacaine for Post-Operative Pain Control After Cystectomy

Phase 3

Active, not recruiting

Conditions: Cystectomy

Interventions: Drug: epidural bupivacaine 0.05%
Drug: Liposomal bupivacaine
Drug: bupivacaine 0.5%
Drug: /hydromorphone 0.05mg/ml
Drug: bupivacaine 0.125%
Drug: injectable saline

First Posted Date: 2020-03-09

Last Posted Date: 2023-05-16

Lead Sponsor: Indiana University

Target Recruit Count: 160

Registration Number: NCT04300231

Locations: 🇺🇸
Indiana Univeristy, Indianapolis, Indiana, United States

Optimal Morphine Dosing Schedule for Neonatal Abstinence Syndrome

Phase 4

Completed

Conditions: Neonatal Abstinence Syndrome
Neonatal Opioid Withdrawal
Neonatal Opioid Withdrawal Syndrome

Interventions: Drug: Morphine scheduled
Drug: Morphine PRN

First Posted Date: 2020-03-06

Last Posted Date: 2022-10-06

Lead Sponsor: Indiana University

Target Recruit Count: 17

Registration Number: NCT04298853

Locations: 🇺🇸
Indiana University Health Methodist Hospital, Indianapolis, Indiana, United States

Chronic Pain OneSheet Clinical Trial

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Behavioral: Chronic Pain OneSheet

First Posted Date: 2020-03-04

Last Posted Date: 2024-05-24

Lead Sponsor: Indiana University

Target Recruit Count: 137

Registration Number: NCT04295135

Locations: 🇺🇸
Wake Forest University, Winston-Salem, North Carolina, United States
🇺🇸
Indiana University, Indianapolis, Indiana, United States

Canine-Assisted ANxiety Reduction IN Emergency Care IV

Not Applicable

Withdrawn

Conditions: Chronic Pain
Anxiety Acute

Interventions: Other: Control
Other: Dog Therapy

First Posted Date: 2020-02-27

Last Posted Date: 2023-07-20

Lead Sponsor: Indiana University

Registration Number: NCT04287452

Locations: 🇺🇸
Eskenazi Health System, Indianapolis, Indiana, United States

M-Health for Teen Substance Abuse and Mental Illness Pilot

Not Applicable

Withdrawn

Conditions: Adolescent Behavior
Post Traumatic Stress Disorder
Substance Use Disorders
Mental Health Disorder

First Posted Date: 2020-02-24

Last Posted Date: 2022-04-06

Lead Sponsor: Indiana University

Registration Number: NCT04281719

Predictors of Recovery Expectancy

Completed

Conditions: Pelvic Organ Prolapse
Surgery

First Posted Date: 2020-02-18

Last Posted Date: 2022-03-31

Lead Sponsor: Indiana University

Target Recruit Count: 202

Registration Number: NCT04274491

Locations: 🇺🇸
Indiana University Urogynecology, Indianapolis, Indiana, United States

Reducing Risk of Dementia Through Deprescribing

Not Applicable

Recruiting

Conditions: Alzheimer Disease, Late Onset
Dementia

Interventions: Other: Deprescribing of target anticholinergics
Other: Usual Care

First Posted Date: 2020-02-17

Last Posted Date: 2024-06-20

Lead Sponsor: Indiana University

Target Recruit Count: 344

Registration Number: NCT04270474

Locations: 🇺🇸
Indiana University Health, Indianapolis, Indiana, United States
🇺🇸
Community Health Network Foundation, Inc., Indianapolis, Indiana, United States
🇺🇸
Eskenazi Health, Indianapolis, Indiana, United States

Exercise Intervention in Adolescent and Young Adult Cancer Survivors

Not Applicable

Recruiting

Conditions: Pediatric Cancer
Long-term Effects Secondary to Cancer Therapy in Adults

Interventions: Behavioral: Exercise

First Posted Date: 2020-02-11

Last Posted Date: 2023-11-28

Lead Sponsor: Indiana University

Target Recruit Count: 66

Registration Number: NCT04265638

Locations: 🇺🇸
Riley Hospital for Children - Indiana University, Indianapolis, Indiana, United States
🇺🇸
IU Health North Hospital, Carmel, Indiana, United States
🇺🇸
Indianapolis Healthplex, Indianapolis, Indiana, United States

Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function

Phase 3

Terminated

Conditions: Kidney Failure

Interventions: Drug: Tacrolimus
Drug: Everolimus

First Posted Date: 2020-02-06

Last Posted Date: 2023-05-24

Lead Sponsor: Indiana University

Target Recruit Count: 4

Registration Number: NCT04258423

Locations: 🇺🇸
Indiana University, Indianapolis, Indiana, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy